Mouse Model Services

Mouse Model Services Market Outlook

The global mouse model services market is expected to reach approximately USD 1.5 billion by the year 2035, growing at a compound annual growth rate (CAGR) of around 7.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing demand for specialized animal models in research, particularly in drug development and cancer research. Additionally, advancements in genetic engineering technologies and a rise in the prevalence of chronic diseases have prompted pharmaceutical and biotechnology companies to invest heavily in mouse model services. The growing number of academic and research institutions focusing on translational medicine has also contributed significantly to the market expansion. Furthermore, government funding and support for research initiatives worldwide have fueled the growth of this market.

Growth Factor of the Market

One of the primary growth factors propelling the mouse model services market is the continuous evolution of biopharmaceutical research and development that necessitates the use of more sophisticated animal models for accurate results. As disease pathophysiology becomes increasingly complex, traditional models are often insufficient, leading to a demand for more specific and tailored mouse models. Additionally, the increasing focus on personalized medicine is driving researchers to utilize mouse models for the development of targeted therapeutics and treatments. The high cost of drug development and the subsequent need for effective preclinical testing further enhance the demand for mouse model services. Furthermore, collaborations between academic institutions and biotech companies to foster innovation in disease modeling are paving the way for novel applications and services. The ongoing advancements in genetic engineering techniques, such as CRISPR-Cas9, are also playing a critical role in the expansion of this market by enabling the creation of precise genetic modifications in mouse models.

Key Highlights of the Market

• The market is projected to witness a CAGR of 7.5% from 2025 to 2035.
• Increased research funding and investment in biopharmaceutical R&D drive demand.
• Technological advancements in genetic modification techniques enhance service offerings.
• Collaboration between academic and research institutions is fostering innovation.
• Rising prevalence of chronic diseases necessitates advanced mouse models for research.

By Service Type

Breeding:

Breeding services play a crucial role in the mouse model services market, as they provide the foundational stock required for various experimental studies. These services include the generation of inbred, outbred, and genetically engineered mouse strains that are tailored to meet specific research needs. The demand for breeding services has increased significantly due to the need for standardized mouse models that ensure reproducibility and reliability in research results. Furthermore, the emphasis on developing specific pathogen-free (SPF) mouse lines has driven research institutions to seek professional breeding services that comply with stringent health and genetic standards. As researchers become more focused on niche areas such as immunology and cancer biology, the need for specialized breeding techniques continues to grow, thus contributing to the expansion of this segment within the mouse model services market.

Rederivation:

Rederivation services are essential for ensuring the health and genetic integrity of mouse models. These services involve the transfer of mouse strains from contaminated or non-SPF environments to clean facilities, thereby preventing the transmission of pathogens. The rising awareness regarding the importance of using SPF mouse models in research has led to an increase in demand for rederivation services. This segment is particularly critical for pharmaceutical and biotechnology companies that require high-quality mouse models for reliable and valid results. The advancements in reproductive technologies, coupled with an increasing number of research studies focusing on genetic diseases and immunological responses, have further propelled the growth of the rederivation segment within the mouse model services market.

Cryopreservation:

Cryopreservation services involve the freezing and storage of mouse embryos and sperm to preserve genetic resources for future use. This segment is gaining traction due to its role in maintaining biodiversity and allowing researchers to manage mouse colonies effectively. Cryopreservation helps mitigate the risk of genetic drift and infection, ensuring that valuable mouse strains remain available for research. Moreover, the increasing focus on long-term storage solutions for genetically modified strains has further expanded the demand for cryopreservation services. With the advent of advanced cryopreservation techniques, researchers are now able to achieve higher survival rates and successful re-establishment of frozen strains, significantly enhancing the overall utility of cryopreservation in mouse model services.

Genetic Modification:

The genetic modification segment has witnessed substantial growth, driven by technological advancements such as CRISPR-Cas9 and other genome-editing tools. These technologies have revolutionized the way researchers design and create mouse models with specific gene alterations to study various diseases. The ability to generate transgenic, knockout, and knock-in mice with precise genetic changes has allowed scientists to investigate complex disease mechanisms in greater detail. Furthermore, as the demand for personalized medicine increases, genetic modification services are becoming increasingly important in developing mouse models that closely mimic human disease phenotypes. This segment's growth is also supported by collaborations between research institutions and biotechnology companies focusing on innovative therapies, further solidifying the role of genetic modification in the overall mouse model services market.

Phenotyping:

Phenotyping services are essential for characterizing the physical and biological traits of mouse models, providing valuable insights into gene function and disease mechanisms. The growing emphasis on understanding the genetic basis of diseases has led to an increased demand for comprehensive phenotyping services. These services often involve a range of assessments, including behavioral tests, metabolic profiling, and physiological measurements. As researchers seek to connect genotype with phenotype, the demand for these specialized services continues to grow. Furthermore, advancements in high-throughput phenotyping technologies have accelerated the pace of research, allowing for the rapid and efficient characterization of mouse models. This segment is particularly relevant for academic institutions and pharmaceutical companies focused on drug discovery and development, driving the overall growth of the mouse model services market.

By Application

Drug Development:

Drug development is one of the primary applications of mouse model services, as these models provide critical insights into the efficacy and safety of therapeutic candidates. The increasing demand for novel therapeutics, coupled with the high costs associated with drug discovery, has led researchers to rely heavily on mouse models for preclinical testing. These models help identify potential side effects and pharmacokinetic properties, facilitating informed decision-making in the drug development process. Furthermore, the growing prevalence of chronic diseases, such as cancer and neurological disorders, is driving the need for more sophisticated mouse models to evaluate new treatment strategies effectively. As a result, the drug development application segment is expected to witness significant growth in the coming years, leading to increased investments in mouse model services.

Toxicology:

Toxicology studies are crucial for assessing the safety of new compounds and understanding their effects on biological systems. Mouse models are widely used in toxicology research due to their genetic similarity to humans and the ability to mimic human disease states. The rising regulatory requirements for drug safety testing have intensified the need for reliable and reproducible toxicology studies using mouse models. Researchers can evaluate the potential toxic effects of substances on various organ systems, contributing to informed decision-making in the pharmaceutical industry. The increasing focus on reducing animal testing through alternative methods has also spurred the development of advanced toxicology models, further driving the demand for mouse model services in this application area.

Cancer Research:

Cancer research represents a significant application area for mouse model services, as these models are instrumental in studying tumor biology, metastasis, and therapeutic responses. The use of genetically engineered mouse models has revolutionized cancer research by enabling scientists to explore the genetic alterations associated with different cancer types. These models allow researchers to test novel therapeutic agents and study their effects in a controlled environment, leading to the development of more effective cancer treatments. As the global burden of cancer continues to rise, the demand for advanced mouse models to facilitate innovative research and drug discovery is expected to grow significantly, driving the expansion of the cancer research application segment.

Immunology:

Immunology is another critical application for mouse model services, as these models are essential for understanding immune system functioning and the development of immunotherapies. Mouse models are used extensively to study autoimmune diseases, infectious diseases, and the immune response to vaccines. The increasing prevalence of immune-related disorders has heightened the demand for accurate and relevant animal models to investigate disease mechanisms and test new treatments. Additionally, the growing interest in immuno-oncology has further underscored the importance of mouse models in developing and evaluating novel immunotherapeutic approaches. As researchers continue to explore the complexities of the immune system, the immunology application segment within the mouse model services market is poised for significant growth.

Neurology:

The field of neurology is rapidly evolving, with mouse models serving as pivotal tools for studying neurodegenerative diseases, brain function, and behavioral disorders. The increasing incidence of neurological disorders, such as Alzheimer's and Parkinson's disease, has accelerated the demand for mouse model services to facilitate research in this area. Mouse models enable researchers to investigate molecular pathways involved in disease progression and identify potential therapeutic targets. Furthermore, the development of advanced behavioral assays in mouse models has allowed for more comprehensive studies of neurological conditions. As the understanding of brain function and its disorders improves, the neurology application segment is expected to see significant growth, contributing to the overall expansion of the mouse model services market.

By User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are among the primary users of mouse model services, as these models are critical for the development and testing of new drugs. These companies rely on mouse models to conduct preclinical studies, evaluate the safety and efficacy of therapeutic agents, and gain insights into disease mechanisms. The increasing investment in drug discovery and development initiatives has elevated the demand for high-quality mouse models that can provide reliable data. Moreover, pharmaceutical companies are increasingly adopting personalized medicine approaches, necessitating the use of specialized mouse models that mimic specific patient populations. As these companies continue to innovate and expand their product pipelines, the demand for mouse model services is expected to grow significantly.

Academic & Research Institutions:

Academic and research institutions play a vital role in advancing scientific knowledge and innovation, often utilizing mouse model services to support their research endeavors. These institutions conduct a wide range of studies, from basic biological research to applied translational research, frequently employing mouse models to investigate various diseases and therapeutic strategies. The increasing emphasis on interdisciplinary research and collaborations between academia and industry has driven the demand for mouse model services within these institutions. Additionally, funding from government and private organizations for research initiatives continues to bolster the utilization of mouse models in academic settings. As research efforts expand and evolve, the academic and research institutions segment is expected to contribute significantly to the overall growth of the mouse model services market.

Contract Research Organizations:

Contract Research Organizations (CROs) serve as essential partners for pharmaceutical and biotechnology companies, providing a range of services, including mouse model services. CROs often have specialized expertise and infrastructure to conduct preclinical studies, making them valuable resources for companies seeking to outsource specific research tasks. The increasing trend of outsourcing research and development activities has led to a growing reliance on CROs for mouse model services. These organizations can offer customized solutions tailored to the unique needs of their clients, facilitating efficient and effective research processes. As the demand for outsourced services continues to rise, the contract research organizations segment is expected to see significant growth in the mouse model services market.

By Mouse Type

Inbred Mice:

Inbred mice are widely used in research due to their genetic uniformity and stable phenotypes, making them ideal for various experimental studies. These mice have been bred for many generations to create genetically homogeneous populations, which enhances reproducibility in research findings. Inbred mouse strains are frequently employed in immunology, cancer research, and behavioral studies, where consistent genetic backgrounds are crucial for accurate results. The demand for inbred mice continues to grow as researchers increasingly recognize the importance of genetic consistency in experimental design. Moreover, the availability of a wide range of established inbred strains allows scientists to select appropriate models that align with their specific research objectives, further driving the growth of this segment in the mouse model services market.

Outbred Mice:

Outbred mice are characterized by their genetic diversity, resulting from the mating of unrelated individuals. This genetic variability makes outbred mice valuable for studies focused on population-based research, drug efficacy, and toxicity testing. Researchers often utilize outbred mice to model human diseases more accurately, as the genetic differences can provide insights into the variability observed in human populations. The growing utilization of outbred mice in preclinical studies is fueled by the increasing recognition of the importance of genetic diversity in research outcomes. Moreover, the expanding portfolio of commercially available outbred mouse strains has added to the accessibility and attractiveness of using these models, contributing to the overall growth of the outbred mice segment in the mouse model services market.

Genetically Engineered Mice:

Genetically engineered mice have revolutionized biomedical research by allowing scientists to investigate gene function and disease mechanisms at an unprecedented level of detail. These mice are created using advanced genetic modification techniques, enabling researchers to develop models that closely mimic human diseases. The increasing focus on personalized medicine and targeted therapies has significantly boosted the demand for genetically engineered mice, as these models can be tailored to reflect specific genetic alterations found in patients. Moreover, the ability to create transgenic, knockout, or knock-in mice has opened new avenues for research across multiple disciplines, including oncology, neurology, and cardiovascular disease. As the field of genetic engineering continues to evolve, the genetically engineered mice segment is expected to experience substantial growth in the mouse model services market.

Hybrid/Congenic Mice:

Hybrid and congenic mice are essential for studying the interaction between different genetic backgrounds and their influence on phenotypic traits. Hybrid mice are produced by crossing two different inbred strains, leading to varied genetic compositions that can be advantageous for specific research applications. Congenic mice, on the other hand, are developed to isolate and study specific genes or genetic loci by backcrossing a hybrid mouse with one of the original inbred strains. The increasing demand for hybrid and congenic mice stems from the need for models that can accurately represent complex genetic traits and disease susceptibility. As researchers seek to unravel the genetic underpinnings of various disorders, the hybrid and congenic mice segment is anticipated to grow significantly within the mouse model services market.

Spontaneous Mutant Mice:

Spontaneous mutant mice are valuable resources for researchers studying genetic diseases and their underlying mechanisms. These mice develop genetic mutations naturally, providing insights into the phenotypic consequences of specific gene alterations. The increasing interest in understanding the genetic basis of diseases has propelled the demand for spontaneous mutant mice, as they often serve as models for studying human conditions. Researchers utilize these mouse models to investigate disease progression, test potential therapies, and explore gene-environment interactions. As the field of genetics continues to advance, the spontaneous mutant mice segment is expected to witness significant growth, further contributing to the overall expansion of the mouse model services market.

By Region

North America holds a dominant position in the mouse model services market, accounting for more than 45% of the global market share in 2023. The region's strong presence of pharmaceutical and biotechnology companies, coupled with significant investment in research and development, drives the demand for mouse model services. Additionally, an increasing number of academic institutions and research organizations in the U.S. and Canada are focusing on innovative research approaches, further contributing to market growth. Moreover, the presence of advanced research facilities and a favorable regulatory environment in North America supports the adoption of mouse models in various research applications. The region is expected to maintain its growth trajectory, with a projected CAGR of 7.8% from 2025 to 2035.

Europe is another significant region in the mouse model services market, with a market share of approximately 25% in 2023. The growing focus on personalized medicine and the increasing prevalence of chronic diseases across European countries are fueling the demand for mouse model services. Countries such as Germany, the U.K., and France are leading contributors to this growth due to their robust pharmaceutical and biotechnology sectors. Additionally, collaborative research initiatives between academia and industry in Europe have led to innovative developments in mouse model services, further enhancing market prospects. The European region is anticipated to see steady growth, with a projected CAGR of 6.7% during the forecast period.

Opportunities

The mouse model services market presents a wealth of opportunities driven by advancements in genetic engineering and a growing understanding of disease biology. One of the key opportunities lies in the increasing demand for personalized medicine, which necessitates the development of specific mouse models that accurately reflect human genetic diversity. As the healthcare landscape shifts towards more tailored therapeutic approaches, mouse model services that support the creation of customized models will be in high demand. Additionally, ongoing research initiatives aimed at understanding complex diseases such as cancer, diabetes, and neurodegenerative disorders continue to fuel the need for sophisticated mouse models. This trend opens new avenues for service providers to innovate and expand their offerings, ultimately enhancing their competitive positioning in the market.

Furthermore, collaborations between research institutions, biotechnology firms, and pharmaceutical companies are expected to generate significant growth opportunities in the mouse model services market. As these collaborations often involve the sharing of expertise and resources, they facilitate the development of novel mouse models that can be used for cutting-edge research. Companies that are agile and adaptable in responding to the evolving needs of their partners and clients will be well-positioned for success. Additionally, the rising focus on ethical considerations in animal research is prompting the development of alternative mouse models that minimize animal use while still providing valuable data. Embracing these opportunities and investing in innovative solutions will be crucial for stakeholders aiming to thrive in the expanding mouse model services market.

Threats

Despite the growth potential in the mouse model services market, several threats can hinder its expansion. One such threat is the increasing scrutiny surrounding animal research and ethical considerations in using animal models. Regulatory bodies and advocacy groups are increasingly advocating for the development of alternative research methods that minimize or eliminate the use of animals. This trend may lead to decreased demand for traditional mouse model services, impacting revenue streams for service providers. Additionally, the development of advanced in vitro and computational models may pose a competitive threat by offering researchers alternative methods for studying biological processes without using live animals. As the scientific community continues to advance toward more humane approaches, stakeholders in the mouse model services market must adapt to these changing dynamics while ensuring compliance with regulatory standards.

Another significant threat facing the mouse model services market is the potential for genetic drift and health issues associated with breeding practices. Maintaining genetic consistency and avoiding contamination of mouse colonies is critical for ensuring reliable research results. However, challenges such as inbreeding depression, the emergence of unexpected genetic mutations, and pathogen introduction can compromise the integrity of mouse models. Service providers must implement rigorous quality control measures and health monitoring protocols to mitigate these risks. Failure to address these concerns may lead to declining trust among researchers, ultimately impacting the growth and sustainability of the mouse model services market. Stakeholders must remain vigilant and proactive in addressing threats to maintain confidence in the value of mouse models in scientific research.

Competitor Outlook

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences
• Envigo
• Harlan Laboratories
• InVivoscribe Technologies
• Eurofins Scientific
• Celerion
• genOway
• KOMP2
• Transgenic Animals
• STEMCELL Technologies
• Xenogen Corporation
• Cyagen Biosciences
• 3M

The competitive landscape of the mouse model services market is characterized by the presence of both established players and emerging companies. Major players such as Charles River Laboratories, The Jackson Laboratory, and Envigo dominate the market due to their extensive experience, comprehensive service offerings, and strong market presence. These companies continually invest in research and development to enhance their capabilities and develop innovative solutions that address the evolving needs of researchers. They also engage in strategic partnerships and collaborations with academic institutions and biotechnology companies to expand their service portfolio and maintain a competitive edge.

Charles River Laboratories is recognized as a leading provider of mouse model services, offering a wide range of services, including breeding, genetic modification, and phenotyping. The company's commitment to quality and compliance with regulatory standards has positioned it as a trusted partner for pharmaceutical companies and academic institutions alike. Similarly, The Jackson Laboratory is renowned for its extensive repository of inbred mouse strains and expertise in genetic research. The company's focus on advancing scientific knowledge and supporting researchers' needs has garnered a loyal customer base.

Emerging companies such as Cyagen Biosciences and genOway are also making significant contributions to the mouse model services market. These companies leverage advanced genetic engineering technologies and innovative approaches to provide customized mouse models tailored to specific research objectives. Their agility and focus on niche markets enable them to capture emerging opportunities and respond rapidly to changing customer demands. As the market continues to evolve, these emerging players may challenge established competitors, driving innovation and enhancing service offerings across the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 KOMP2
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Envigo
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 genOway
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Celerion
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Cyagen Biosciences
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Transgenic Animals
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Eurofins Scientific
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Harlan Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Taconic Biosciences
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Xenogen Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 STEMCELL Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 The Jackson Laboratory
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 InVivoscribe Technologies
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Charles River Laboratories
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Mouse Model Services Market, By User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Academic & Research Institutions
    • 6.1.3 Contract Research Organizations
  • 6.2 Mouse Model Services Market, By Mouse Type
    • 6.2.1 Inbred Mice
    • 6.2.2 Outbred Mice
    • 6.2.3 Genetically Engineered Mice
    • 6.2.4 Hybrid/Congenic Mice
    • 6.2.5 Spontaneous Mutant Mice
  • 6.3 Mouse Model Services Market, By Application
    • 6.3.1 Drug Development
    • 6.3.2 Toxicology
    • 6.3.3 Cancer Research
    • 6.3.4 Immunology
    • 6.3.5 Neurology
  • 6.4 Mouse Model Services Market, By Service Type
    • 6.4.1 Breeding
    • 6.4.2 Rederivation
    • 6.4.3 Cryopreservation
    • 6.4.4 Genetic Modification
    • 6.4.5 Phenotyping

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Mouse Model Services Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Mouse Model Services market is categorized based on

By Service Type

• Breeding
• Rederivation
• Cryopreservation
• Genetic Modification
• Phenotyping

By Application

• Drug Development
• Toxicology
• Cancer Research
• Immunology
• Neurology

By User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Contract Research Organizations

By Mouse Type

• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice
• Hybrid/Congenic Mice
• Spontaneous Mutant Mice

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences
• Envigo
• Harlan Laboratories
• InVivoscribe Technologies
• Eurofins Scientific
• Celerion
• genOway
• KOMP2
• Transgenic Animals
• STEMCELL Technologies
• Xenogen Corporation
• Cyagen Biosciences
• 3M